AC
ZBH icon

ASB Consultores’s Zimmer Biomet ZBH Stock Holding History

ASB Consultores’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,110
Closed -$329K – 232
2024
Q4 		$329K Hold
3,110
– – 0.14% 130
2024
Q3 		$336K Sell
3,110
-175
-5% -$19.1K 0.13% 129
2024
Q2 		$357K Sell
3,285
-17
-0.5% -$2K 0.13% 113
2024
Q1 		$436K Buy
+3,302
New +$412K 0.11% 134
2023
Q3 		– Sell
-1,617
Closed -$235K – 200
2023
Q2 		$235K Sell
1,617
-25
-2% -$3.4K 0.11% 158
2023
Q1 		$212K Hold
1,642
– – 0.09% 172
2022
Q4 		$209K Buy
+1,642
New +$191K 0.09% 180
2022
Q2 		– Sell
-1,642
Closed -$210K – 238
2022
Q1 		$210K Buy
+1,642
New +$198K 0.09% 211

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ASB Consultores's ZBH Position: Q1 2025 in Review

ASB Consultores sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 3,110 shares — an estimated $329K sold.

ASB Consultores first reported a position in ZBH in Q1 2022 and held it in 8 quarters. The position peaked at $436K in Q1 2024. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • ASB Consultores reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • ASB Consultores sold 3,110 Zimmer Biomet shares in Q1 2025, an estimated $329K.
  • ASB Consultores first reported a position in Zimmer Biomet in Q1 2022 and held it in 8 quarters.
  • ASB Consultores's Zimmer Biomet position peaked at $436K in Q1 2024.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on ASB Consultores's 13F filing for Q1 2025, filed 13 May 2025.